Exelon reinstated with an Outperform, added to Focus List at Credit Suisse Credit Suisse reinstated Exelon with an Outperform rating and $42 price target and added shares to the U.S. Focus List. The firm said Exelon offers leverage to the the ongoing power market recovery and views the recent pull back as a buying opportunity.
Exelon upgraded to Outperform from Market Perform at Wells Fargo Wells Fargo upgraded Exelon to Outperform citing an attractive risk/reward ahead of likely reforms in the capacity market. Wells expects reforms to positively impact the value of ExGenís 19 GW nuclear fleet. It raised its price target range for shares to $43-$44 from $41-$42.